Table 1.
Pre- and post-implementation encounter characteristics
| Pre-indication encounters (N=648) | Post-indication encounters (N=645) | |
|---|---|---|
| Providers | 100 | 91 |
| Antibiotic | ||
| Amoxicillin | 208 (32.1%) | 182 (28.2%) |
| Amoxicillin/clavulanate | 102 (15.7%) | 123 (19.1%) |
| Cefdinir | 61 (9.4%) | 47 (7.3%) |
| Azithromycin | 58 (9.0%) | 57 (8.8%) |
| Cephalexin | 51 (7.9%) | 54 (8.4%) |
| Doxycycline | 47 (7.3%) | 63 (9.8%) |
| Nitrofurantoin | 36 (5.6%) | 31 (4.8%) |
| Sulfamethoxazole/ Trimethoprim | 30 (4.6%) | 31 (4.8%) |
| Clindamycin | 17 (2.6%) | 16 (2.5%) |
| Penicillin | 13 (2.0%) | 11 (1.7%) |
| Metronidazole | 11 (1.7%) | 3 (0.5%) |
| Ciprofloxacin | 9 (1.4%) | 17 (2.6%) |
| Levofloxacin | 4 (0.6%) | 5 (0.8%) |
| Cefuroxime | 1 (0.2%) | 2 (0.3%) |
| Clarithromycin | 0 (0.0%) | 2 (0.3%) |
| Fosfomycin | 0 (0.0%) | 1 (0.2%) |
| Charted diagnosis | ||
| Group A streptococcus | 221 (34.1%) | 196 (30.4%) |
| Skin/soft tissue infection | 81 (12.5%) | 94 (14.6%) |
| Sinusitis | 83 (12.8%) | 86 (13.3%) |
| Urinary tract infection | 76 (11.7%) | 91 (14.1%) |
| Acute otitis media | 74 (11.4%) | 76 (11.8%) |
| Pneumonia | 27 (4.2%) | 19 (3.0%) |
| Bronchitis | 26 (4.0%) | 18 (2.8%) |
| Prophylaxis | 21 (3.2%) | 14 (2.2%) |
| Other | 39 (6.0%) | 51 (7.9%) |
| Congruence charted diagnosis vs ICD10 code | 540 (83.3%) | 566 (87.8%) |
| Congruence charted diagnosis vs mandatory indication | 614 (95.2%) |
Percentage reflects the percentage of total encounters within pre- or post-implementation groups, respectively. Charter diagnosis of “Other” includes Intestinal infection, Viral Upper Respiratory Tract Infection, Patient Request, Histoplasmosis, Septic Joint, Chronic Obstructive Pulmonary Disease Exacerbation, Bacterial Vaginosis, Tonsillitis and Pharyngitis Not Otherwise Specified, Dental Infection, Sexually Transmitted Infections, Tickborne Illness, Appendicitis, Prostatitis, COVID, Asthma, and Epididymitis.